Therapeutic Expertise
For seventeen years, Axiom Pharmaceuticals has built its reputation one therapeutic area at a time — not by spreading thin across every category the market offers, but by going deep where it matters most: the nervous system, the gut, growing bodies, and recovering ones. What started as a small team with a vision for accessible, quality healthcare has grown into a portfolio that physicians across Pakistan reach for when precision counts.
We don’t claim to do everything. We claim to do a few things well, backed by formulations that hold up to scrutiny and a supply chain that doesn’t let patients down.
Neurology & Neuropsychiatry
This is where Axiom started, and it’s still where we spend the most time thinking. Migraine, epilepsy, dementia, mood disorders, and psychiatric conditions don’t respond to guesswork — they respond to consistent dosing, the right molecule, and a formulation that a patient can actually stay on long-term.
Our AxRibo and AxRibo Plus line was one of the earlier Riboflavin-CoQ10-Magnesium combinations introduced for migraine prophylaxis in this market, and it remains a reference point for how we approach neurological care: combine what the evidence supports, skip what doesn’t add value, and make it affordable enough that patients actually finish the course.
From anticonvulsants like Lacosamide and Topiramate, to antipsychotics including Olanzapine, Risperidone, and Aripiprazole, to antidepressants spanning SSRIs and SNRIs, our neuropsychiatric portfolio is built for the physicians managing the hardest conversations in medicine — chronic, relapsing, stigmatized conditions that need a partner in pharma, not just a vendor.
We also carry this commitment beyond the prescription pad. Supporting neurodivergent and epileptic children — through awareness, access, and better long-term outcomes — isn’t a side initiative for us. It’s close to why the company exists.
Gastroenterology & Prokinetics
Digestive health rarely gets the attention it deserves until something goes wrong. Our prokinetic agents — Itopride and Levosulpiride among them — are formulated for the everyday GI complaints that quietly erode quality of life: dysmotility, bloating, the overlap between gut symptoms and mood that so many patients describe but few formularies address well.
Pediatrics
Children aren’t small adults, and we don’t formulate for them as though they are. Our pediatric vitamin and mineral lines — ADEK and zinc combinations, iron bisglycinate for anemia, vitamin D3-K2 solutions — are built around absorption, taste tolerance, and the realities of getting a reluctant child to actually take a dose consistently. A supplement a child won’t take is not a solution.
Orthopedics, Pain & Mobility
From acute musculoskeletal pain to chronic neuropathic conditions, our analgesic range — NSAIDs like Lornoxicam and Piroxicam-beta-cyclodextrin, muscle relaxants, and pregabalin-based neuropathic agents — is built for the realities of recovery: pain that needs fast control without compromising the patient’s ability to function or heal.
Nutraceuticals & Vitamins
Not every patient is managing a disease state. Many are simply trying to stay well, recover faster, or fill a nutritional gap. Our nutraceutical range — Omega-3 formulations, CoQ10, L-Carnitine, calcium, multivitamins — exists for that patient too, formulated with the same quality standards we apply to our prescription portfolio.
What Holds It Together
Every product we put our name on is manufactured through partnerships with quality-controlled facilities, developed against recognized pharmaceutical standards, and documented the way a clinician expects when they’re deciding what to put their name behind too. That’s not a marketing line — it’s the baseline we don’t compromise on, because the people on the other end of these prescriptions are someone’s patient, someone’s parent, someone’s child.
Our expertise isn’t measured by the size of our catalog. It’s measured by how many physicians keep coming back to the same few molecules from us, year after year, because they work, and because we’re still here to stand behind them.